Madoiwa S, Arai K, Ueda Y, Ishizuka M, Mimuro J, Asakura S, Matsuda M, Sakata Y
Division of Hemostasis and Thrombosis, Jichi Medical School, Tochigi.
J Biochem. 1997 Feb;121(2):278-87. doi: 10.1093/oxfordjournals.jbchem.a021584.
Two groups of anti-plasminogen monoclonal antibodies, whose epitope was either in the kringle 1 + 2 + 3 domain (F3P2, F11P5, F11P6, and F12P18) or the kringle 5 domain (F1P6 and F12P16), were isolated and their effects on the conformation of plasminogen were explored. All antibodies except F1P6 had 3- to 10-fold higher affinity toward Lys-plasminogen than Glu-plasminogen. F1P6 exhibited a comparable affinity to Glu- and Lys-plasminogen. Among these, only F11P5 binding was inhibited by epsilon-amino-nu-caproic acid (EACA) in a concentration-dependent manner, with half maximal inhibition at 3 mM. From a competition assay, we concluded that the epitopes of F11P5, F11P6, and F12P18 should be very close, and located at or near the low affinity lysine binding site on the kringle 2 + 3. These three antibodies dramatically enhanced the binding of Glu-plasminogen to the other antibodies, except to F1P6. Interestingly, F3P2, whose non-overlapping epitope was in the kringle 2 + 3 domain, also augmented the binding of Glu-plasminogen to the other antibodies. In contrast, we did not observe enhanced binding of Lys-plasminogen to one antibody in the presence of the other antibodies, and the binding of Glu-plasminogen to these antibodies did not increase in the presence of 10 mM EACA. In the presence of these antibodies, including F1P6, Glu-plasminogen bound more efficiently to immobilized degraded fibrin, with a binding profile similar to Lys-plasminogen. All antibodies except F1P6 enhanced the conversion rate of plasminogen to plasmin remarkably. Taken together, we propose that these two groups of monoclonal antibodies can dissociate the intramolecular interactions of Glu-plasminogen and induce the conformational transition of Glu-plasminogen to Lys-plasminogen. In addition, the kringle 2 + 3 and kringle 5 structures of Glu-plasminogen liganded with EACA are distinct from the Lys-plasminogen structure.
分离出两组抗纤溶酶原单克隆抗体,其表位分别位于kringle 1 + 2 + 3结构域(F3P2、F11P5、F11P6和F12P18)或kringle 5结构域(F1P6和F12P16),并探讨了它们对纤溶酶原构象的影响。除F1P6外,所有抗体对赖氨酸纤溶酶原的亲和力比对谷氨酸纤溶酶原的亲和力高3至10倍。F1P6对谷氨酸纤溶酶原和赖氨酸纤溶酶原表现出相当的亲和力。其中,只有F11P5的结合被ε-氨基-己酸(EACA)以浓度依赖性方式抑制,在3 mM时半数最大抑制。通过竞争试验,我们得出结论,F11P5、F11P6和F12P18的表位应该非常接近,并且位于kringle 2 + 3上低亲和力赖氨酸结合位点处或附近。这三种抗体显著增强了谷氨酸纤溶酶原与其他抗体(除F1P6外)的结合。有趣的是,其不重叠表位位于kringle 2 + 3结构域的F3P2也增强了谷氨酸纤溶酶原与其他抗体的结合。相反,在存在其他抗体的情况下,我们未观察到赖氨酸纤溶酶原与一种抗体的结合增强,并且在10 mM EACA存在下,谷氨酸纤溶酶原与这些抗体的结合并未增加。在包括F1P6在内的这些抗体存在下,谷氨酸纤溶酶原更有效地结合到固定化的降解纤维蛋白上,其结合模式类似于赖氨酸纤溶酶原。除F1P6外的所有抗体均显著提高了纤溶酶原向纤溶酶的转化率。综上所述,我们提出这两组单克隆抗体可以解离谷氨酸纤溶酶原的分子内相互作用,并诱导谷氨酸纤溶酶原向赖氨酸纤溶酶原的构象转变。此外,与EACA结合的谷氨酸纤溶酶原的kringle 2 + 3和kringle 5结构与赖氨酸纤溶酶原结构不同。